Hyperglucagonemia
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Role of the Kidneys and Liver in the Elimination of Glucagon (NCT05056584) | University Hospital, Gentofte, Copenhagen | 2020-08-01 |
| Effects of Glucagon Administration on Energy Expenditure (NCT02237053) | AdventHealth Translational Research Institute | 2014-09-01 |
| Role of Aprotinin in Glucagon Degradation, Measurement by Radioimmunoactive Method (RIA) I125 (NCT01436734) | University Hospital, Gentofte, Copenhagen | 2011-07-01 |
| Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes (NCT00704795) | University Hospital, Gentofte, Copenhagen | 2008-06-01 |
| Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM) (NCT00862589) | University Hospital, Gentofte, Copenhagen | 2006-10-01 |
Track Hyperglucagonemia automatically
Every clearance here is in the API, with alerts when new ones post.